# Virology Specimen Collection Market

> Virology Specimen Collection Market Size, Growth Research Report By Product Type (Swabs, Viral Transport Media, Blood Collection Kits, and Others), By Application (Diagnostics and Research), By End User (Hospitals & Clinics, Diagnostic Centers, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Competitor Industry Analysis and Trends Forecast Till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.3%
- **2024:** $ 6.42 Billion
- **2025:** $ 6.76 Billion
- **2035:** $ 11.34 Billion
- **Key Players:** Thermo Fisher Scientific (US), BD (US), Roche Diagnostics (CH), Abbott Laboratories (US), Qiagen (DE), PerkinElmer (US), Hologic (US), Meridian Bioscience (US), Bio-Rad Laboratories (US)

**Report ID:** MRFR/HC/9314-HCR · **Pages:** 120 · **Author:** Rahul Gotadki · **Last Updated:** April 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/virology-specimen-collection-market-10798

---

## Market Summary

## **Virology Specimen Collection Market Overview**

As per MRFR analysis, the Virology Specimen Collection Market Size was estimated at 6.42 (USD Billion) in 2024. The Virology Specimen Collection Market Industry is expected to grow from 6.76 (USD Billion) in 2025 to 10.77 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.30% during the forecast period (2025 - 2034).

_Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review_

In April 2021, MediBuddy, a digital healthcare platform that operates without the need for payment, introduced a COVID-19 laboratory exam for individuals residing in Mumbai, Pune, and New Delhi. The test is conducted by authorized pathological laboratories that are listed by the government. The prescription for the test will be obtained through an online doctor consultation, following the ICMR criteria.

## **Virology Specimen Collection Market Trends**

One of the main factors driving up the demand for efficient virology specimen collection is the increased prevalence of viral infections like AIDS, the flu, SARS-CoV-2, EBOLA, STDs, and the Zika virus. The World Health Organisation (WHO) estimates that at the end of 2020, there were 37.7 million HIV-positive persons worldwide. Out of these, the WHO African Region was home to over two-thirds (25.4 million) of the population. In 2020, 1.5 million (1.0-2.0 million) individuals contracted the illness, and around 680,000 people perished from HIV-related causes.

Additionally, according to information released by the World Health Organisation (WHO) in July 2021, there were reportedly 7 million new cases of syphilis worldwide in 2020. Over 1 million sexually transmitted diseases (STIs) are contracted every day worldwide, according to data released by the World Health Organisation (WHO) in November 2021. This is then expected to further fuel the market for virology specimen collection.

Nasopharyngeal (NP) swabs are expected to increase in popularity as antigen tests become available to close timing and capacity limitations in the testing landscape. The appearance of the infectious Delta version of COVID-19 has also raised the need for tests in recent months. For instance, in August 2020, the US Department of Defence awarded a contract worth USD 51 million to Puritan Medical Products (US) in coordination with the Department of Health and Human Services (HHS).

The money is intended to help the company increase its monthly production capacity of flock tip testing swabs to 50 million swabs by March 2021 to facilitate coronavirus testing.

In addition, the rising incidence of viral diseases and the appearance of new pathogens are anticipated to be the main drivers of the market's expansion. The World Health Organisation (WHO) estimates that in 2021, various infectious diseases affected 60% of the world's population. The need for virology specimen collection has increased as a result of the expanding prevalence of viral infections such the human immunodeficiency virus (HIV), influenza, Ebola, Zika virus, and other STDs. 

The Human Immunodeficiency Virus (HIV) was present in 38.4 million people as of the World Health Organization's (WHO) January 2021 update. Likewise, according to a Food and Agriculture Organisation (FAO) report released in January 2022, China recorded 13 new instances of the avian influenza virus while the United Kingdom reported 5 cases. Due to the effective detection and treatment of viral illnesses, the rising frequency of viral diseases and the advent of new viral infections has increased the demand for virology specimen collections, which will drive the market's growth during the ensuing years.

Thus, driving the Virology Specimen Collection market revenue.

## **Virology Specimen Collection Market Segment Insights**

### **Virology Specimen Collection Product Type Insights**

The Virology Specimen Collection market segmentation, based on product type, includes swabs, viral transport media, blood collection kits, and others. Swabs segment dominated the market in 2022. Swabs are tiny bits of soft material that are used to clean cuts, collect a tiny amount of substance from the body for testing, or both. The Centres for Disease Control and Prevention (CDC) reported that there are two ways to package sterile swabs for collecting upper respiratory specimens: either individually wrapped or in bulk.

### **Virology Specimen Collection Application Insights**

The Virology Specimen Collection market segmentation, based on application, includes diagnostics and research. Diagnosis segment dominated the market in 2022. The virology specimen collection kit allows samples to be taken from the patient's nose using an approved self-collection kit that contains nasal swabs and saline to diagnose the condition based on the patient's symptoms and indicators.

### **Virology Specimen Collection End User Insights**

The Virology Specimen Collection market segmentation, based on end user, includes hospitals & clinics, diagnostic centers, and others. Hospitals & clinics segment dominated the Virology Specimen Collection market in 2022.This is due to an increase in patients with respiratory virus infections and the rising need for viral disease treatment and diagnostics. Due to the unexpected surge in COVID-19 infectious cases around the world, there was also an increase in the demand for virology specimen collection.

**Figure 1: Virology Specimen Collection Market, by End User, 2022 & 2032 (USD Billion)** 

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

### **Virology Specimen Collection Regional Insights**

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Virology Specimen Collection Market dominated this market in 2022 (45.80%). Laboratory Corporation of America (LabCorp) will be the first diagnostic test developer for an at-home specimen collection kit for COVID-19, according to the US Food and Drug Administration (FDA), in April 2020. During the projected period, it is anticipated that this will increase demand for virology specimen collection throughout the region. Further, the U.S.

Virology Specimen Collection market held the largest market share, and the Canada Virology Specimen Collection market was the fastest growing market in the North America region.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

**Figure 2: VIROLOGY SPECIMEN COLLECTION MARKET SHARE BY REGION 2022 (USD Billion)** 

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

Europe Virology Specimen Collection market accounted for the healthy market share in 2022. The World Health Organisation (WHO) and the European Centre for Disease Prevention and Control (ECDC) are cooperating closely to determine the laboratory needs and capacities in the European region, according to the WHO's January 2020 report. As a result of the growth in COVID-19 cases and the occurrence of viral infections, sample collection kits are needed for laboratory tests and detection.

This is anticipated to fuel the market's expansion for virology specimen collection.Further, the German Virology Specimen Collection market held the largest market share, and the U.K Virology Specimen Collection market was the fastest growing market in the European region.

The Asia Pacific Virology Specimen Collection market is expected to register significant growth from 2023 to 2032. The Asian Development Bank (ADB) announced in April 2021 a USD 31.6 billion aid package for the Asia and Pacific area in 2020 to address the epidemic and boost green and sustainable green recovery in response to the outbreak of COVID-19 infections. Therefore, the virology specimen collecting market is anticipated to rise as a result of an increase in government financing.

Moreover, China’s Virology Specimen Collection market held the largest market share, and the Indian Virology Specimen Collection market was the fastest growing market in the Asia-Pacific region.

**Virology Specimen Collection Key Market Players & Competitive Insights**

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Virology Specimen Collection market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Virology Specimen Collection Industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Virology Specimen Collection Industry to benefit clients and increase the market sector. In recent years, the Virology Specimen Collection Industry has offered some of the most significant advantages to medicine.

Major players in the Virology Specimen Collection market, including Hardy Diagnostics, Puritan Medical Products, COPAN Diagnostics, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., BNTX Inc., Formlabs, Medline Industries, Inc., Laboratory Corporation of America Holdings, VIRCELL S.L., Lucence Diagnostics Pte Ltd., and HiMedia Laboratories, are attempting to increase market demand by investing in research and development operations.

The company Covaris, LLC creates sophisticated sample preparation tools for genomic and proteomic research. The business provides technologies for tools, kits, tubes and vials, reagents, and accessories, enabling customers to discover new things, create new assays, and enhance bioanalytical outcomes. The truXTRAC viral RNA extraction kit and the truXTRAC-[PCR](../../../reports/real-time-pcr-qpcr-market-10672) direct viral RNA extraction kit are two new kits that Covaris, LLC introduced in February 2020 for the extraction of viral RNA from nose or throat swab sample collecting devices.

For tests like COVID-19, Rhinostics creates sample collecting kits to improve the productivity, accuracy, and security of labs. In comparison to traditional sample collecting methods, the company's patient-centric sample collection offers efficiencies to the laboratory that remove costs and save time, allowing labs to cut time and labour costs, increase safety, reduce sample contamination, and lower error rates. With the introduction of the VERIstic collection equipment designed specifically for tiny volume blood collection in the United States in July 2022, Rhinostics made a significant advancement in automated sample collection technology.

**Key Companies in the Virology Specimen Collection market include**

### Virology Specimen Collection Market Industry Developments

- **Q2 2024: BD Launches New Swab Collection System for Viral Diagnostics** BD announced the launch of its new BD ESwab™ 2.0 Collection and Transport System, designed to improve the stability and recovery of viral specimens for diagnostic testing, expanding its virology specimen collection portfolio.
- **Q1 2024: Thermo Fisher Scientific Expands Viral Transport Media Production Facility in North Carolina** Thermo Fisher Scientific opened a new production line at its North Carolina facility to increase output of viral transport media, supporting global demand for virology specimen collection products.
- **Q2 2024: Roche Receives CE Mark for New Cobas PCR Media Dual Swab Kit** Roche announced it has received CE Mark approval for its Cobas PCR Media Dual Swab Kit, enabling more efficient collection and transport of virology specimens for molecular testing in Europe.
- **Q3 2024: QIAGEN Launches QIAstat-Dx Viral Panel with Enhanced Specimen Collection Kit** QIAGEN introduced an upgraded QIAstat-Dx Viral Panel, featuring a new specimen collection kit designed to improve sample integrity and workflow for virology diagnostics.
- **Q2 2024: FDA Authorizes New Self-Collection Swab for At-Home Viral Testing** The FDA granted Emergency Use Authorization to a new self-collection swab device for at-home collection of virology specimens, expanding access to diagnostic testing.
- **Q1 2024: Puritan Medical Products Announces $25 Million Expansion for Swab Manufacturing** Puritan Medical Products announced a $25 million investment to expand its manufacturing capacity for viral specimen collection swabs at its Maine facility.
- **Q2 2024: Copan Diagnostics Partners with NHS to Supply Virology Collection Kits** Copan Diagnostics entered a partnership with the UK National Health Service to supply advanced virology specimen collection kits for use in public health laboratories.
- **Q3 2024: Greiner Bio-One Launches New Saliva Collection Device for Viral Testing** Greiner Bio-One launched a new saliva collection device aimed at improving the ease and accuracy of virology specimen collection for both clinical and research applications.
- **Q2 2024: Roche Acquires Minority Stake in SwabTech, a Virology Collection Device Startup** Roche announced the acquisition of a minority stake in SwabTech, a startup specializing in innovative virology specimen collection devices, to accelerate product development.
- **Q1 2025: Thermo Fisher Scientific Appoints New VP of Global Specimen Collection Business** Thermo Fisher Scientific named Dr. Lisa Chen as Vice President of its Global Specimen Collection Business, overseeing strategy and operations for virology specimen collection products.
- **Q2 2025: BD Receives FDA Clearance for Next-Generation Viral Transport Medium** BD received FDA clearance for its next-generation viral transport medium, designed to enhance the stability and safety of virology specimen collection and transport.
- **Q2 2024: Copan Diagnostics Opens New European Distribution Center** Copan Diagnostics opened a new distribution center in the Netherlands to streamline delivery of virology specimen collection kits across Europe.

## **Virology Specimen Collection Market Segmentation**

### **Virology Specimen Collection Product Type Outlook**

### **Virology Specimen Collection Application Outlook**

### **Virology Specimen Collection End User Outlook**

### **Virology Specimen Collection Regional Outlook**

## Market Drivers

### Market Growth Projections

The Global Virology Specimen Collection Market Industry is projected to experience substantial growth over the next decade. With a market value anticipated to reach 6.42 USD Billion in 2024 and further escalate to 11.3 USD Billion by 2035, the industry is poised for a robust expansion. The compound annual growth rate (CAGR) of 5.31% from 2025 to 2035 indicates a sustained upward trajectory, driven by factors such as technological advancements, increased demand for testing, and enhanced government support. This growth reflects the critical role of specimen collection in addressing global health challenges and improving disease management.

### Growing Focus on Personalized Medicine

The shift towards personalized medicine is influencing the Global Virology Specimen Collection Market Industry, as healthcare providers seek tailored treatment approaches based on individual patient profiles. This trend necessitates precise specimen collection methods to ensure accurate diagnostics and treatment plans. As healthcare systems increasingly adopt personalized strategies, the demand for high-quality specimens is expected to rise. This evolution in medical practice underscores the importance of reliable specimen collection, which is essential for the successful implementation of personalized therapies. Consequently, this focus on individualized care may drive market expansion in the coming years.

### Increased Government Initiatives and Funding

Government initiatives aimed at improving public health infrastructure are significantly impacting the Global Virology Specimen Collection Market Industry. Increased funding for virology research and specimen collection programs is being observed globally, as governments recognize the importance of preparedness against viral outbreaks. This financial support facilitates the development of better collection protocols and training for healthcare professionals. Furthermore, public health campaigns are raising awareness about the importance of specimen collection in disease management. Such initiatives are likely to bolster market growth, as they enhance the capacity for effective viral surveillance and response.

### Rising Demand for Infectious Disease Testing

The Global Virology Specimen Collection Market Industry is experiencing heightened demand for infectious disease testing, driven by the increasing prevalence of viral infections. As healthcare systems worldwide prioritize early detection and diagnosis, the market is projected to reach 6.42 USD Billion in 2024. This surge is indicative of a broader trend towards proactive healthcare measures, where timely specimen collection plays a crucial role in managing outbreaks and ensuring public health safety. Enhanced awareness among populations regarding viral diseases further fuels this demand, suggesting a sustained growth trajectory for the industry.

### Emerging Markets and Global Health Initiatives

Emerging markets are playing a pivotal role in the Global Virology Specimen Collection Market Industry, as global health initiatives aim to enhance disease surveillance and response capabilities. Countries in regions such as Africa and Southeast Asia are receiving increased attention due to their vulnerability to viral outbreaks. International collaborations and funding are being directed towards improving specimen collection infrastructure in these areas, which is crucial for effective disease monitoring. As these markets develop their healthcare systems, the demand for virology specimen collection is likely to grow, contributing to the overall expansion of the industry.

### Technological Advancements in Collection Methods

Technological innovations are transforming the Global Virology Specimen Collection Market Industry, with advancements in collection methods enhancing efficiency and accuracy. Novel devices and automated systems are being developed to streamline specimen collection processes, thereby reducing the risk of contamination and improving sample integrity. For instance, the introduction of self-collection kits has empowered patients to participate in their own healthcare, potentially increasing testing rates. As these technologies continue to evolve, they are likely to contribute to the market's growth, which is expected to reach 11.3 USD Billion by 2035, reflecting a robust CAGR of 5.31% from 2025 to 2035.

## Future Outlook

The Virology Specimen Collection Market is projected to grow at a 5.3% CAGR from 2025 to 2035, driven by technological advancements, increasing demand for diagnostics, and enhanced healthcare infrastructure.

**New opportunities:**

- Development of mobile specimen collection units for remote areas. Integration of AI-driven analytics for specimen processing efficiency. Expansion of partnerships with telehealth platforms for specimen collection services.

By 2035, the market is expected to be robust, reflecting substantial growth and innovation.

## Segment Insights

### By Application: Diagnostic Testing (Largest) vs. Research and Development (Fastest-Growing)

In the Virology Specimen Collection Market, the application segment is primarily driven by Diagnostic Testing, which commands the largest market share. It encompasses various methodologies for the detection of viral pathogens, significantly influencing collection techniques and consumable utilization. On the other hand, Research and Development constitutes a growing part of the market dynamic. Its share is increasingly being recognized due to heightened focus on innovation in virology, leading to specialized specimen collection methods tailored for advanced testing contexts.

Diagnostic Testing (Dominant) vs. Research and Development (Emerging)

Diagnostic Testing is the dominant application in the Virology Specimen Collection Market, characterized by its extensive integration in healthcare settings. It involves standardized procedures and tools aimed at ensuring the accurate and timely identification of viral infections. In contrast, Research and Development represents an emerging segment that is fast catching up. This area focuses on creating advanced methodologies for specimen collection that support innovative research on viral pathogens, catering to a more diverse range of studies and trials that extend beyond conventional diagnostics.

### By Type of Specimen: Blood (Largest) vs. Saliva (Fastest-Growing)

The Virology Specimen Collection Market is distinctly characterized by its diverse specimen types, with blood being the largest segment due to its wide applicability in [virology testing](https://www.marketresearchfuture.com/reports/virology-testing-market-40225) and diagnostics. Saliva, while smaller in traditional usage, has garnered significant attention as an efficient, non-invasive alternative for viral specimen collection, thus demonstrating its potential for rapid growth in the market. In contrast, other sample types like urine, tissue, and nasal [swabs](https://www.marketresearchfuture.com/reports/swab-market-834) hold varying degrees of market presence, primarily driven by specific virological applications. As the demand for efficient and patient-friendly diagnostic options rises, saliva specimens are emerging as the fastest-growing choice among healthcare providers. Growth drivers include technological advancements in saliva collection kits, increasing awareness of non-invasive testing, and the flexibility of saliva specimens in screening and monitoring viral infections. Consequently, this upward trend in saliva usage is expected to reshape the landscape of virology specimen collection over the coming years.

Blood (Dominant) vs. Saliva (Emerging)

Blood specimens hold a dominant position in the Virology Specimen Collection Market due to their established reliability and utility in detecting a wide array of viral infections. The thoroughness of viral load measurements achievable through blood samples solidifies their preference among laboratories and healthcare providers. In contrast, saliva specimens represent an emerging market segment, gaining traction because of their ease of collection and reduced patient discomfort. These factors are driving innovations in saliva-based testing approaches, making it an attractive option for at-home testing and population-wide screening initiatives. As the healthcare landscape evolves, both specimen types are likely to coexist, catering to different segments of the market, with blood continuing to lead while saliva demonstrates robust growth.

### By Collection Method: Automated Collection (Largest) vs. Self-Collection (Fastest-Growing)

The virology specimen collection market is characterized by diverse collection methods, with Automated Collection taking a significant share due to its efficiency and accuracy. Traditional methods, while still valuable, are gradually being overshadowed by innovations in automation. Self-Collection is gaining traction, particularly among patients seeking convenience and quicker results, thereby enhancing its position in this competitive market. Manual Collection remains relevant but is challenged by the evolving preferences for more efficient solutions. Growth trends in the collection method segment are influenced by technological advancements and changing patient behaviors. Automation is being adopted for its reliability and reduced risk of contamination, whereas Self-Collection is being driven by the increasing demand for home testing options. Healthcare providers are also exploring ways to improve operational efficiency, further fueling the rise of these collection methods in various settings.

Automated Collection (Dominant) vs. Self-Collection (Emerging)

Automated Collection currently dominates the virology specimen collection market due to its streamlined processes, enhanced accuracy, and ability to handle a higher volume of samples with consistency. This method minimizes human error and is favored in clinical laboratories for its efficiency in processing specimens. In contrast, Self-Collection is emerging as a preferred alternative, advocated by its convenience and the growing trend of at-home health testing. This method allows patients to collect specimens at their convenience, which is particularly appealing in a post-pandemic world. With empowered consumers and healthcare innovations pushing boundaries, both segments are evolving but with distinct characteristics that cater to different market needs.

### By End User: Hospitals (Largest) vs. Diagnostic Laboratories (Fastest-Growing)

In the Virology Specimen Collection Market, Hospitals dominate the landscape, servicing a significant portion of the overall specimen collection needs. They cater to a large patient base, supported by infrastructure that emphasizes rapid and reliable specimen collection methods. On the other hand, Diagnostic Laboratories are quickly gaining traction, accounting for an increasing share of the market as they become more integral in providing accurate diagnoses through specialized testing.

End Users: Hospitals (Dominant) vs. Diagnostic Laboratories (Emerging)

Hospitals are the dominant end user in the Virology Specimen Collection Market due to their extensive resources and the critical need for efficient specimen collection from patients undergoing testing. They leverage advanced technologies and trained personnel to handle a high volume of specimen collection effectively. Conversely, Diagnostic Laboratories are emerging as a key player, primarily due to the rising demand for precise diagnostic services. Their rapid growth is fueled by technological advancements and an increasing focus on specialized virology tests, making them a vital component of the healthcare ecosystem.

## Regional Market Share Analysis

### North America : Market Leader in Virology

North America is poised to maintain its leadership in the Virology Specimen Collection Market, holding a significant market share of 3.5 billion in 2024. The region's growth is driven by increasing healthcare expenditure, advancements in diagnostic technologies, and a robust regulatory framework that supports innovation. The rising prevalence of viral infections and the demand for efficient specimen collection methods further fuel market expansion. The United States stands out as the leading country, hosting major players like Thermo Fisher Scientific, BD, and Abbott Laboratories. The competitive landscape is characterized by continuous innovation and strategic partnerships among key players. The presence of advanced healthcare infrastructure and a focus on research and development contribute to the region's dominance in the global market.

### Europe : Emerging Market Dynamics

Europe's Virology Specimen Collection Market is projected to grow, with a market size of 1.8 billion. Key growth drivers include increasing awareness of viral diseases, supportive government initiatives, and advancements in healthcare technologies. The region benefits from stringent regulatory standards that ensure high-quality specimen collection, which is crucial for accurate diagnostics and treatment. Leading countries such as Germany, France, and the UK are at the forefront of this market, with significant contributions from companies like Roche Diagnostics and Qiagen. The competitive landscape is marked by innovation and collaboration among industry players, enhancing the region's capability to address emerging health challenges. The European market is expected to see continued investment in research and development to improve specimen collection methods.

### Asia-Pacific : Rapid Growth Potential

The Asia-Pacific region is witnessing rapid growth in the Virology Specimen Collection Market, with a market size of 1.5 billion. Factors driving this growth include increasing healthcare investments, rising awareness of viral infections, and a growing population. The region's diverse healthcare landscape and improving access to diagnostic services are also significant contributors to market expansion. Countries like China, India, and Japan are leading the charge, with a mix of local and international players such as PerkinElmer and Hologic. The competitive environment is evolving, with a focus on enhancing product offerings and expanding distribution networks. As the region continues to develop its healthcare infrastructure, the demand for efficient specimen collection solutions is expected to rise significantly.

### Middle East and Africa : Developing Market Landscape

The Middle East and Africa region is gradually emerging in the Virology Specimen Collection Market, with a market size of 0.62 billion. Key growth drivers include increasing healthcare investments, rising incidences of viral diseases, and government initiatives aimed at improving healthcare infrastructure. The region's diverse demographics and varying healthcare needs present both challenges and opportunities for market players. Countries like South Africa and the UAE are leading the market, with a growing presence of international companies. The competitive landscape is characterized by a mix of local and The Virology Specimen Collection share. As healthcare systems evolve, the demand for reliable specimen collection methods is expected to grow, paving the way for future investments in this sector.

## Competitive Benchmarking

The Virology Specimen Collection Market is currently characterized by a dynamic competitive landscape, driven by the increasing demand for efficient and reliable specimen collection methods. Key players such as Thermo Fisher Scientific (US), BD (US), and Roche Diagnostics (CH) are strategically positioned to leverage their extensive product portfolios and technological advancements. These companies are focusing on innovation and partnerships to enhance their market presence. For instance, Thermo Fisher Scientific (US) has been investing in R&D to develop next-generation specimen collection devices, which could potentially improve diagnostic accuracy and patient outcomes. 

This collective emphasis on innovation and strategic collaborations among major players is shaping a competitive environment that prioritizes quality and efficiency.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market appears to be moderately fragmented, with several players vying for market share. However, the influence of key players like Abbott Laboratories (US) and Qiagen (DE) is notable, as they continue to expand their global footprint through strategic acquisitions and partnerships. This competitive structure suggests that while there is room for smaller players, the dominance of established companies is likely to shape market trends and consumer preferences.
In November BD (US) announced a strategic partnership with a leading telehealth provider to integrate specimen collection services into remote patient monitoring systems. This move is significant as it aligns with the growing trend of digital health solutions, potentially enhancing patient access to testing and improving overall healthcare delivery. By leveraging telehealth capabilities, BD (US) is likely to strengthen its market position and cater to the evolving needs of healthcare providers and patients alike.
In October Roche Diagnostics (CH) launched a new line of automated specimen collection systems designed to streamline laboratory workflows. This innovation is crucial as it addresses the increasing demand for efficiency in laboratory operations, particularly in high-throughput environments. The introduction of such advanced systems may not only enhance Roche's competitive edge but also set new standards for operational excellence in the industry.
In September Abbott Laboratories (US) expanded its product offerings by acquiring a startup specializing in mobile specimen collection technologies. This acquisition is indicative of Abbott's commitment to innovation and its strategy to diversify its portfolio. By integrating mobile solutions, Abbott is likely to enhance patient convenience and accessibility, which could be a key differentiator in the market.
As of December current competitive trends in the Virology Specimen Collection Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are playing a pivotal role in shaping the landscape, as companies seek to combine resources and expertise to drive innovation. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and innovative solutions that meet the changing demands of healthcare providers and patients.

## Recent News & Developments

- **Q2 2024: BD Launches New Swab Collection System for Viral Diagnostics** BD announced the launch of its new BD ESwab™ 2.0 Collection and Transport System, designed to improve the stability and recovery of viral specimens for diagnostic testing, expanding its virology specimen collection portfolio.
- **Q1 2024: Thermo Fisher Scientific Expands Viral [Transport Media](https://www.marketresearchfuture.com/reports/transport-media-market-42628)Production Facility in North Carolina** Thermo Fisher Scientific opened a new production line at its North Carolina facility to increase output of viral transport media, supporting global demand for virology specimen collection products.
- **Q2 2024: Roche Receives CE Mark for New Cobas PCR Media Dual Swab Kit** Roche announced it has received CE Mark approval for its Cobas PCR Media Dual Swab Kit, enabling more efficient collection and transport of virology specimens for molecular testing in Europe.
- **Q3 2024: QIAGEN Launches QIAstat-Dx Viral Panel with Enhanced Specimen Collection Kit** QIAGEN introduced an upgraded QIAstat-Dx Viral Panel, featuring a new specimen collection kit designed to improve sample integrity and workflow for virology diagnostics.
- **Q2 2024: FDA Authorizes New Self-Collection Swab for At-Home Viral Testing** The FDA granted Emergency Use Authorization to a new self-collection swab device for at-home collection of virology specimens, expanding access to diagnostic testing.
- **Q1 2024: Puritan Medical Products Announces $25 Million Expansion for Swab Manufacturing** Puritan Medical Products announced a $25 million investment to expand its manufacturing capacity for viral specimen collection swabs at its Maine facility.
- **Q2 2024: Copan Diagnostics Partners with NHS to Supply Virology Collection Kits** Copan Diagnostics entered a partnership with the UK National Health Service to supply advanced virology specimen collection kits for use in public health laboratories.
- **Q3 2024: Greiner Bio-One Launches New Saliva Collection Device for Viral Testing** Greiner Bio-One launched a new saliva collection device aimed at improving the ease and accuracy of virology specimen collection for both clinical and research applications.
- **Q2 2024: Roche Acquires Minority Stake in SwabTech, a Virology Collection Device Startup** Roche announced the acquisition of a minority stake in SwabTech, a startup specializing in innovative virology specimen collection devices, to accelerate product development.
- **Q1 2025: Thermo Fisher Scientific Appoints New VP of Global Specimen Collection Business** Thermo Fisher Scientific named Dr. Lisa Chen as Vice President of its Global Specimen Collection Business, overseeing strategy and operations for virology specimen collection products.
- **Q2 2025: BD Receives FDA Clearance for Next-Generation Viral Transport Medium** BD received FDA clearance for its next-generation viral transport medium, designed to enhance the stability and safety of virology specimen collection and transport.
- **Q2 2024: Copan Diagnostics Opens New European Distribution Center** Copan Diagnostics opened a new distribution center in the Netherlands to streamline delivery of virology specimen collection kits across Europe.

## Report Scope

| MARKET SIZE 2024 | 6.42(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 6.76(USD Billion) |
| MARKET SIZE 2035 | 11.34(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.3% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Thermo Fisher Scientific (US), BD (US), Roche Diagnostics (CH), Abbott Laboratories (US), Qiagen (DE), PerkinElmer (US), Hologic (US), Meridian Bioscience (US), Bio-Rad Laboratories (US) |
| Segments Covered | Application, Type of Specimen, End User |
| Key Market Opportunities | Integration of advanced automation technologies enhances efficiency in the Virology Specimen Collection Market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation in virology specimen collection methodologies and practices. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Virology Specimen Collection Market?**
A: As of 2024, the market valuation stands at 6.42 USD Billion.

**Q: What is the projected market size for the Virology Specimen Collection Market by 2035?**
A: The market is expected to reach a valuation of 11.34 USD Billion by 2035.

**Q: What is the expected CAGR for the Virology Specimen Collection Market during the forecast period?**
A: The market is anticipated to grow at a CAGR of 5.3% from 2025 to 2035.

**Q: Which application segment is projected to have the highest growth in the Virology Specimen Collection Market?**
A: The Diagnostic Testing segment is expected to grow from 2.56 USD Billion in 2024 to 4.56 USD Billion by 2035.

**Q: What types of specimens are most commonly collected in the Virology Specimen Collection Market?**
A: Nasal Swabs are projected to grow significantly, from 1.72 USD Billion in 2024 to 3.34 USD Billion by 2035.

**Q: How does the collection method impact the Virology Specimen Collection Market?**
A: Transport Media is expected to see substantial growth, increasing from 2.72 USD Billion in 2024 to 4.04 USD Billion by 2035.

**Q: Which end-user segment is likely to dominate the Virology Specimen Collection Market?**
A: Hospitals are projected to lead the market, growing from 2.56 USD Billion in 2024 to 4.56 USD Billion by 2035.

**Q: Who are the key players in the Virology Specimen Collection Market?**
A: Key players include Thermo Fisher Scientific, BD, Roche Diagnostics, and Abbott Laboratories, among others.

**Q: What is the growth potential for research institutions in the Virology Specimen Collection Market?**
A: Research Institutions are expected to grow from 1.28 USD Billion in 2024 to 2.24 USD Billion by 2035.

**Q: How does the market for automated collection compare to manual collection in the Virology Specimen Collection Market?**
A: Automated Collection is projected to increase from 1.2 USD Billion in 2024 to 2.0 USD Billion by 2035, indicating a growing trend towards automation.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/virology-specimen-collection-market-10798*